Get started
Author

Fengjun Guo

Observed names: F J Guo, F.J. Guo, FENG-JUN GUO, FENGJUN GUO, Feng-Jun Guo, Feng-jun Guo, Feng‐Jun Guo
ORCID: 0000-0003-0130-9694
Observed ORCID: 0000-0003-0130-9694
OpenAlex ID: A5030633656
Serum microRNA-92 expression in patients with ovarian epithelial carcinoma
2013 · Fengjun Guo, Jingyan Tian, et al. · Journal of International Medical Research · 71
Nanoliposomal formulation encapsulating celecoxib and genistein inhibiting COX-2 pathway and Glut-1 receptors to prevent prostate cancer cell proliferation
2019 · Jingyan Tian, Fengjun Guo, et al. · Cancer Letters · 70
Phosphorylation of STAT3 at Tyr705 regulates MMP-9 production in epithelial ovarian cancer
2017 · Zan-Hui Jia, Yan Jia, et al. · PLoS ONE · 68
Microarray analysis of microRNA deregulation and angiogenesis-related proteins in endometriosis
2016 · R.Q. Yang, H. Teng, et al. · Genetics and Molecular Research · 64
PDF
Prostate cancer: updates on current strategies for screening, diagnosis and clinical implications of treatment modalities
2017 · Jing-Yan Tian, Feng-Jun Guo, et al. · Carcinogenesis · 45
A novel inhibitory role of microRNA‐224 in particulate matter 2.5‐induced asthmatic mice by inhibiting TLR2
2020 · Ping Li, Jinpeng Wang, et al. · Journal of Cellular and Molecular Medicine · 40
PDF
Chemoresistance and targeting of growth factors/cytokines signalling pathways: towards the development of effective therapeutic strategy for endometrial cancer.
2018 · Fengjun Guo, Haina Zhang, et al. · Europe PMC (PubMed Central) · 40
PSMA conjugated combinatorial liposomal formulation encapsulating genistein and plumbagin to induce apoptosis in prostate cancer cells
2021 · Jing-yan Tian, Chang-liang Chi, et al. · Colloids and Surfaces B Biointerfaces · 34
Nanocarrier-based targeting of metabolic pathways for endometrial cancer: Status and future perspectives
2023 · Yichao Wang, Siyao Chen, et al. · Biomedicine & Pharmacotherapy · 18
Downregulation of matrix metalloproteinase 9 by small interfering RNA inhibits the tumor growth of ovarian epithelial carcinoma in vitro and in vivo
2012 · FENGJUN GUO, JINGYAN TIAN, et al. · Molecular Medicine Reports · 16
PDF
MIR-92 stimulates VEGF by inhibiting von Hippel-Lindau gene product in epithelial ovarian cancer.
2017 · F J Guo, Y P Shao, et al. · PubMed · 13
Evaluation of the potential of ultrasound-mediated drug delivery for the treatment of ovarian cancer through preclinical studies
2022 · Yi-Chao Wang, Jing-Yan Tian, et al. · Frontiers in Oncology · 9
PDF
Effects of cyclooxygenase-2 gene silencing on the biological behavior of SKOV3 ovarian cancer cells
2014 · FENG-JUN GUO, JING-YAN TIAN, et al. · Molecular Medicine Reports · 9
PDF
A novel GPCR target in correlation with androgen deprivation therapy for prostate cancer drug discovery
2020 · Jing‐Yan Tian, Chang‐Liang Chi, et al. · Basic & Clinical Pharmacology & Toxicology · 7
PDF
Retracted : Impaired Th17 cell proliferation and decreased pro‐inflammatory cytokine production in CXCR3/CXCR4 double‐deficient mice of vulvovaginal candidiasis
2019 · Yue‐Mei Jin, Shan‐Shan Liu, et al. · Journal of Cellular Physiology · 5
The Role of F-Fluorodeoxyglucose (FDG) Positron Emission Tomography–Computed Tomography (PET/CT) in the Screening of Cervical Cancer: A Literature Review
2013 · Fengjun Guo, Ruiqi Yang, et al. · Cell Biochemistry and Biophysics · 2
[Retracted] Effects of cyclooxygenase‑2 gene silencing on the biological behavior of SKOV3 ovarian cancer cells
2021 · Feng-Jun Guo, Jing-Yan Tian, et al. · Molecular Medicine Reports · 1
PDF
[Retracted] Downregulation of matrix metalloproteinase 9 by small interfering RNA inhibits the tumor growth of ovarian epithelial carcinoma in vitro and in vivo
2021 · Fengjun Guo, Jingyan Tian, et al. · Molecular Medicine Reports
PDF
Works count: 18
Citation count: 512
H-index: 11
I10-index: 11
Year
Topic
Type